{"transactions":[{"id":802298,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":51565,"kind":"person","name":"PINKSTON ARNOLD A","position":1,"cik":"0001343989","reported_name":"PINKSTON ARNOLD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-04-23T19:23:43.000Z","date":"2026-04-21","kind":"exercise","planned":false,"acquired":false,"shares":407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":407},"source":{"system":"sec-edgar","filing":"0001343989-26-000002","document":"wk-form4_1776972221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000134398926000002/wk-form4_1776972221.xml","form_type":"4"}},{"id":802297,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":51565,"kind":"person","name":"PINKSTON ARNOLD A","position":1,"cik":"0001343989","reported_name":"PINKSTON ARNOLD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-04-23T19:23:43.000Z","date":"2026-04-21","kind":"grant","planned":false,"acquired":true,"shares":369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders."}],"balance_after":369,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":369},"source":{"system":"sec-edgar","filing":"0001343989-26-000002","document":"wk-form4_1776972221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000134398926000002/wk-form4_1776972221.xml","form_type":"4"}},{"id":802296,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":51565,"kind":"person","name":"PINKSTON ARNOLD A","position":1,"cik":"0001343989","reported_name":"PINKSTON ARNOLD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Bio-Rad A Common Stock","published_at":"2026-04-23T19:23:43.000Z","date":"2026-04-21","kind":"exercise","planned":false,"acquired":true,"shares":407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":715,"source":{"system":"sec-edgar","filing":"0001343989-26-000002","document":"wk-form4_1776972221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000134398926000002/wk-form4_1776972221.xml","form_type":"4"}},{"id":1166903,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":51565,"kind":"person","name":"PINKSTON ARNOLD A","position":1,"cik":"0001343989","reported_name":"PINKSTON ARNOLD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-24T21:15:14.000Z","date":"2025-04-22","kind":"exercise","planned":false,"acquired":false,"shares":308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 6, 2024, the reporting person was granted 308 restricted stock units, vesting at 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 6, 2024, the reporting person was granted 308 restricted stock units, vesting at 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":308},"source":{"system":"sec-edgar","filing":"0001062993-25-007908","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299325007908/form4.xml","form_type":"4"}},{"id":1166902,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":51565,"kind":"person","name":"PINKSTON ARNOLD A","position":1,"cik":"0001343989","reported_name":"PINKSTON ARNOLD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-24T21:15:14.000Z","date":"2025-04-22","kind":"grant","planned":false,"acquired":true,"shares":407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders."}],"balance_after":407,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":407},"source":{"system":"sec-edgar","filing":"0001062993-25-007908","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299325007908/form4.xml","form_type":"4"}},{"id":1166901,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":51565,"kind":"person","name":"PINKSTON ARNOLD A","position":1,"cik":"0001343989","reported_name":"PINKSTON ARNOLD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Bio-Rad A Common Stock","published_at":"2025-04-24T21:15:14.000Z","date":"2025-04-22","kind":"exercise","planned":false,"acquired":true,"shares":308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":308,"source":{"system":"sec-edgar","filing":"0001062993-25-007908","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299325007908/form4.xml","form_type":"4"}},{"id":1411561,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":51565,"kind":"person","name":"PINKSTON ARNOLD A","position":1,"cik":"0001343989","reported_name":"PINKSTON ARNOLD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-09-10T17:54:56.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders."}],"balance_after":308,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":308},"source":{"system":"sec-edgar","filing":"0001062993-24-016374","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016374/form4.xml","form_type":"4"}},{"id":3610204,"issuer":{"id":138562,"kind":"organization","name":"CORELOGIC, INC.","symbol":"CLGX"},"owners":[{"id":51565,"kind":"person","name":"PINKSTON ARNOLD A","position":1,"cik":"0001343989","reported_name":"PINKSTON ARNOLD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO & Corporate Secretary"}}],"security":"Common Stock","published_at":"2019-03-06T20:30:37.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":4033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Amount represents performance-based restricted stock units (\"PBRSUs\") granted in 2018 that were credited upon Compensation Committee certification of Issuer's achievement of 2018 performance metric on March 4, 2019."}],"balance_after":24161,"source":{"system":"sec-edgar","filing":"0000036047-19-000040","document":"wf-form4_155192222373217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/36047/000003604719000040/wf-form4_155192222373217.xml","form_type":"4"}},{"id":3617295,"issuer":{"id":138562,"kind":"organization","name":"CORELOGIC, INC.","symbol":"CLGX"},"owners":[{"id":51565,"kind":"person","name":"PINKSTON ARNOLD A","position":1,"cik":"0001343989","reported_name":"PINKSTON ARNOLD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO & Corporate Secretary"}}],"security":"Common Stock","published_at":"2019-03-05T20:52:39.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":1176,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20128,"source":{"system":"sec-edgar","filing":"0000036047-19-000030","document":"wf-form4_155183714457964.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/36047/000003604719000030/wf-form4_155183714457964.xml","form_type":"4"}},{"id":3617294,"issuer":{"id":138562,"kind":"organization","name":"CORELOGIC, INC.","symbol":"CLGX"},"owners":[{"id":51565,"kind":"person","name":"PINKSTON ARNOLD A","position":1,"cik":"0001343989","reported_name":"PINKSTON ARNOLD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO & Corporate Secretary"}}],"security":"Common Stock","published_at":"2019-03-05T20:52:39.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":11968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-vested stock units granted in 2019 that are subject to a performance metric for fiscal 2019."}],"balance_after":21304,"source":{"system":"sec-edgar","filing":"0000036047-19-000030","document":"wf-form4_155183714457964.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/36047/000003604719000030/wf-form4_155183714457964.xml","form_type":"4"}},{"id":4018838,"issuer":{"id":138562,"kind":"organization","name":"CORELOGIC, INC.","symbol":"CLGX"},"owners":[{"id":51565,"kind":"person","name":"PINKSTON ARNOLD A","position":1,"cik":"0001343989","reported_name":"PINKSTON ARNOLD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO & Corporate Secretary"}}],"security":"Common Stock","published_at":"2018-03-05T21:27:06.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":9336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-vested restricted stock units granted in 2018 that are subject to a performance metric for fiscal 2018."}],"balance_after":9336,"source":{"system":"sec-edgar","filing":"0000036047-18-000035","document":"wf-form4_152030321294638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/36047/000003604718000035/wf-form4_152030321294638.xml","form_type":"4"}},{"id":4298452,"issuer":{"id":175616,"kind":"organization","name":"JANUS CAPITAL GROUP INC","symbol":"JNS"},"owners":[{"id":51565,"kind":"person","name":"PINKSTON ARNOLD A","position":1,"cik":"0001343989","reported_name":"PINKSTON ARNOLD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-01T16:49:20.000Z","date":"2017-05-30","kind":"disposition_to_issuer","acquired":false,"shares":8717,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On May 30, 2017, pursuant to that certain Agreement and Plan of Merger, dated as of October 3, 2016 (the \"Merger Agreement\"), by and among Henderson Group plc (\"Henderson\"), a company incorporated in Jersey, Horizon Orbit Corp., a Delaware corporation and direct wholly-owned subsidiary of Henderson (\"Merger Sub\"), and Janus Capital Group Inc., a Delaware corporation (\"JCG\"), JCG and Henderson (which has been renamed as Janus Henderson Group plc (\"Janus Henderson\")) completed the merger-of-equals whereby the Merger Sub merged with and into JCG, with JCG surviving the merger as a direct wholly-owned subsidiary of Janus Henderson (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each share of JCG common stock, par value $0.01 per share (\"Common Stock\"), issued and outstanding immediately prior to the completion of the Merger was automatically converted into the right to receive 0.47190 of a fully paid up Janus Henderson ordinary share, par value Pound 0.125 per share (\"Ordinary Shares\"), together with cash in lieu of any fractional Ordinary Share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-17-036941","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1065865/000110465917036941/a4.xml","form_type":"4"}}]}